WESPAC Advisors
WESPAC Advisors reported 202 stocks worth $198M in its 13F filing for Q3 2026, filed Oct 26, 2026. Its largest holdings are IVV (4.4%), PULS (4.1%) and VT (3.3%). Compared with Q2 2026, the fund opened new positions in PWB, IGV and CRTC, added to IVV, VT and CLOZ, trimmed PULS, VTI and CLOX and sold out of DRAM, BBVA and AHR.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() IVV Ishares TR | $8.7M | 4.4% | 11K | +4,145 (+58%) | 8 of 8 | |
| 2 | ![]() PULS Pgim ETF TR | $8M | 4.1% | 162K | −59K (−27%) | 8 of 8 | |
| 3 | ![]() VT Vanguard Total World | $6.4M | 3.3% | 41K | +3,383 (+9%) | 4 of 8 | |
| 4 | ![]() CLOZ Series Portfolios TR | $5.2M | 2.6% | 196K | +44K (+29%) | 2 of 8 | |
| 5 | ![]() JBND J P Morgan Exchange Traded F | $4.8M | 2.4% | 94K | +3,786 (+4%) | 7 of 8 | |
| 6 | ![]() JIVE J P Morgan Exchange Traded F | $4.5M | 2.3% | 47K | +492 (+1%) | 6 of 8 | |
| 7 | ![]() VTI Vanguard Total Stock Market ETF | $4.4M | 2.2% | 12K | −809 (−6%) | 8 of 8 | |
| 8 | ![]() MRK Merck & Co Inc | $4M | 2.0% | 28K | No change | 4 of 8 | |
| 9 | ![]() CLOX Series Portfolios TR | $4M | 2.0% | 157K | −2,249 (−1%) | 7 of 8 | |
| 10 | ![]() CGDV Capital Group Dividend | $4M | 2.0% | 82K | +1,520 (+2%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() DRAM Roundhill ETF Trust | $1.5M | 21K |
![]() BBVA Banco Bilbao Vizcaya Argenta | $1.4M | 57K |
![]() AHR American Healthcare REIT Inc | $1.3M | 26K |
![]() FIX Comfort Sys USA Inc | $1.3M | 662 |
![]() FWD AB Active Etfs Inc | $914K | 6,173 |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Oct 26, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →WESPAC Advisors 13F FAQ
What does WESPAC Advisors own?
WESPAC Advisors reported 202 stocks worth $198M in its 13F filing for Q3 2026, filed Oct 26, 2026. Its largest holdings are IVV (4.4%), PULS (4.1%) and VT (3.3%). The table above lists every position in the filing (the top 10 without an account).
What did WESPAC Advisors buy and sell in Q3 2026?
Compared with Q2 2026: 40 new positions, 58 added to, 65 trimmed and 38 sold out. New positions include PWB, IGV and CRTC. It sold all of DRAM, BBVA and AHR.
When will WESPAC Advisors file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is WESPAC Advisors's portfolio worth?
The Q3 2026 filing reports $198M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.














